The Emerging Role of Adipokines as Mediators of Cardiovascular Function: Physiologic and Clinical Perspectives
Abstract
Interest in the biology of white adipose tissue has increased dramatically since the discovery of leptin in 1994. The identification of the product of the gene obese (ob) threw light on the role of adipose tissue in the physiopathology of obesity-related diseases and spurred the identification of numerous other adipokines, many of a proinflammatory nature. It has become increasingly evident that white adipose tissue-derived cytokines mediate between obesity-related exogenous factors (nutrition and lifestyle) and the molecular events that lead to metabolic syndrome, inflammation, and cardiovascular diseases. Here we review recent adipokine research, with particular attention to the roles of adiponectin, leptin, resistin, visfatin, apelin, omentin, and chemerin in such conditions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The greatest impact of these endocrinological changes appears related to alterations in sex hormones (testosterone and androgens), growth hormone, and adipokines.
“The greatest impact of these changes appears to be related to alterations in sex hormone (i.e. testosterone and androgens), growth hormone, and a host of adipokines [29,34-46].”
The citation lists haven’t been fetched yet
References 112 · Cited by 193
- Authors
- Gualillo, O., González-Juanatey, J. R., & Lago, F.
- Affiliations
- Complejo Hospitalario Universitario de Santiago (ES)
- Corresponding author
- Lago, Francisca
- Venue
- Trends in Cardiovascular Medicine
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 17
- Issue
- 8
- Pages
- 275-283
- ISSN
- 1050-1738 (ISSN-L)
- OpenAlex
- W2103352453
- Cited by
- 193
- References
- 112
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 7 · 2019: 4 · 2018: 8 · 2017: 9 · 2016: 12 · 2015: 11 · 2014: 14 · 2013: 13 · 2012: 21
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Cardiovascular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Keywords
- adipokines, white adipose tissue, leptin, adiponectin, resistin, visfatin, apelin, omentin, chemerin, obesity, metabolic syndrome, inflammation, cardiovascular disease, cytokines
- MeSH terms
- Cardiovascular Diseases, Cardiovascular System, Humans, Obesity, Cytokines, Chemokines, Leptin, Resistin, Adipokines, Nicotinamide Phosphoribosyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review